EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial)

Natsuda Aumpan iD, Navapan Issariyakulkarn, Varocha Mahachai, David Graham, Yoshio Yamaoka iD, Ratha-Korn Vilaichone iD

PLOS ONE · 30.11.2023 · 18 (11) · e0294403

DOI: 10.1371/journal.pone.0294403 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift PLOS ONE, online erschienen am 30.11.2023. Verfasst von Natsuda Aumpan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Digestive Diseases and Gastroenterology Unit, Department of Medicine, Thammasat University, Pathumthani, Thailand. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED) [e-ASIA JRP], Thailand Science Research and Innovation Fundamental Fund, Bualuang ASEAN Chair Professorship at Thammasat University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Helicobacter pylori treatment failure remains a challenging problem. This study aimed to identify predictive factors for successful eradication in patients following treatment failures.

Methods

This was a retrospective cohort study. This study included 1,050 dyspeptic patients diagnosed with H . pylori infection at tertiary care center in Thailand between March 2014 and October 2021. Patients’ demographic data, endoscopic findings, H . pylori culture, antimicrobial susceptibility testing (AST), treatment regimens and outcomes were analysed.

Results

Of 1,050 patients with H . pylori infections, 302 (28.7%) experienced treatment failure (mean age 58.4 years; 44.7% males). AST was performed in 192. Resistance was observed for metronidazole (43.2%), levofloxacin (33.9%), clarithromycin (24%), and amoxicillin (2.1%). There was no tetracycline resistance. Multidrug-resistance (MDR) was significantly more common following treatment failure (45.5% vs. 15.7%, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriFemaleHumansMaleMiddle AgedAmoxicillinAnti-Bacterial AgentsClarithromycinDrug Therapy, CombinationLevofloxacinMetronidazoleRetrospective StudiesTreatment Failure

Substanzen

AmoxicillinAnti-Bacterial AgentsClarithromycinLevofloxacinMetronidazole

Autor:innen und Institutionen

  • Center of Excellence in Digestive Diseases and Gastroenterology Unit, Department of Medicine, Thammasat University, Pathumthani, Thailand.
  • Department of Medicine, Chulabhorn International College of Medicine (CICM) at Thammasat University, Pathumthani, Thailand.
  • Department of Medicine, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas, United States of America.
  • Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Yufu, Japan.
  • Research Center for Global and Local Infectious Diseases, Oita University, Yufu, Japan.

ORCID-Profile: Natsuda Aumpan, Yoshio Yamaoka, Ratha-Korn Vilaichone

Förderung

  • Japan Agency for Medical Research and Development (AMED) [e-ASIA JRP]
  • Thailand Science Research and Innovation Fundamental Fund
  • Bualuang ASEAN Chair Professorship at Thammasat University
  • Center of Excellence in Digestive Diseases, Thammasat University, Thailand

Zitieren

APA

Aumpan, N., Issariyakulkarn, N., Mahachai, V., Graham, D., Yamaoka, Y., & Vilaichone, R. K. (2023). Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial). PLOS ONE, 18(11), e0294403. https://doi.org/10.1371/journal.pone.0294403

Vancouver

Aumpan N, Issariyakulkarn N, Mahachai V, Graham D, Yamaoka Y, Vilaichone RK. Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial). PLOS ONE. 2023;18(11):e0294403. doi:10.1371/journal.pone.0294403

BibTeX
@article{Aumpan2023,
  author = {Aumpan, Natsuda and Issariyakulkarn, Navapan and Mahachai, Varocha and Graham, David and Yamaoka, Yoshio and Vilaichone, Ratha-Korn},
  title = {Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial)},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {11},
  pages = {e0294403},
  doi = {10.1371/journal.pone.0294403}
}
Kostenlos starten →